Zentalis Pharmaceuticals Inc Share Price

NASDAQ: ZNTL

Small Cap

$1.50

-0.06

(-4.17%)

as on September 13, 2025 at 1:29 am IST

$₹

Zentalis Pharmaceuticals Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$1.49
Day's Price Range
$1.55
$1.5
0.67%
Downside
3.33%
Upside
52 Week's Low
52 Week's High
$1.01
52-Week Price Range
$5.44
$1.5
32.67%
Downside
262.67%
Upside

Zentalis Pharmaceuticals Inc share price movements today

Previous Close: $1.56
Open: $1.54
Volume: 678.6K
Day's Low - High: $1.49 - $1.55
52 Week Low - High: $1.01 - $5.44

Zentalis Pharmaceuticals Inc Historical Returns

1 Month Return: + 9.4 %
3 Month Return: + 21.64 %
1 Year Return: -49.69 %
3 Year Return: -93.84 %
5 Year Return: -94.4 %

Zentalis Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Zentalis Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$107.5M

EPS (TTM)

-1.9571

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-170.4M

Revenue (TTM)

26.9M

Profit Margin

0.00%

Return On Equity TTM

129007800.00%

Zentalis Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zentalis Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Zentalis Pharmaceuticals Inc	BUY	$107.5M	-94.4%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Zentalis Pharmaceuticals Inc Stock including INR - Dollar returns

The Zentalis Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Zentalis Pharmaceuticals Inc investment value today

Current value as on today

₹51,435

Returns

₹48,565

(-48.56%)

Returns from Zentalis Pharmaceuticals Inc Stock

₹53,704 (-53.7%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Zentalis Pharmaceuticals Inc Stock

Based on 17 analysts

BUY

82.35%

Buy

17.65%

Hold

0.00%

Sell

Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Zentalis Pharmaceuticals Inc. Average target price of $6.19

Zentalis Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Zentalis Pharmaceuticals Inc.

What analysts predicted

75.77%UPSIDE

Target Price

$6.19

Current Price

$1.5

Analyzed by

17 Analysts

Target

$6.19

Zentalis Pharmaceuticals Inc target price $6.19, a slight upside of 75.77% compared to current price of $1.5. According to 17 analysts rating.

Zentalis Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Zentalis Pharmaceuticals Inc Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 15, 2025 to September 14, 2025

Change:-9% versus previous 30 day period

Zentalis Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	2	40	-	-	26	-	-
Gross Profit	0	0	0	1	40	0	0	26	0	0
Operating Income	-64	-103	-62	-67	-24	-65	-51	-49	-45	-36
EBITDA	-64	-58	-62	-67	-24	-64	-51	-45	-45	-35
Interest Expense	5	-	-	5	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-60	-99	-55	-61	10	-88	-40	-47	-48	-26
Income Tax Expense	0	0	0	0	0	0	0	0	-	-
Net Income	-60	-112	-55	-60	10	-88	-40	-47	-48	-26
Net Profit Margin	0.00%	0.00%	0.00%	-2895.29%	24.82%	0.00%	0.00%	-176.71%	0.00%	0.00%

Zentalis Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	-	-	-	-	-	67
Gross Profit	0	0	0	0	-1	-1	67
Operating Income	-23	-46	-118	-216	-227	-253	-191
EBITDA	-23	-46	-117	-164	-219	-275	-186
Interest Expense	-	1	2	110	2	-	-
Depreciation	0	0	0	0	1	1	1
Income Before Tax	-23	-46	-118	-164	-221	-292	-165
Income Tax Expense	0	0	0	0	0	0	0
Net Income	-21	-46	-117	-158	-236	-292	-165
Net Profit Margin	-150478.57%	0.00%	0.00%	0.00%	0.00%	0.00%	-245.96%

Zentalis Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-112	-55	-60	10	-88	-40	-47	-48	-26
Operating Cash Flow	-79	-38	-40	-51	-35	-44	-39	-32	-34
Investing Cash Flow	72	-117	-42	61	34	48	32	40	30
Financing Cash Flow	236	0	-	0	0	0	-	0	-
Change in Cash	230	-155	-82	9	0	4	-7	8	-4

Zentalis Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-46	-118	-166	-237	-292	-165
Operating Cash Flow	-39	-86	-154	-163	-207	-170
Investing Cash Flow	0	-284	-18	-114	-44	176
Financing Cash Flow	81	360	178	261	237	0
Change in Cash	42	-11	6	-16	-14	5

Global Institutional Holdings in Zentalis Pharmaceuticals Inc

Funds	Holdings
Matrix Capital Management Company, LLC	19.35%
BlackRock Inc	5.86%
Vanguard Group Inc	4.52%
Millennium Management LLC	4.26%
Acadian Asset Management LLC	3.71%

See all

Insights on Zentalis Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 129.7%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 217.7%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ZNTL stock has moved down by -14.9%

About Zentalis Pharmaceuticals Inc

developing potentially best-in-class, novel small molecules targeting fundamental biological pathways in cancer

Organisation	Zentalis Pharmaceuticals Inc
Headquarters	10275 Science Center Dr., San Diego, CA, United States, 92121
Industry	Health Technology
CEO	Ms. Julie M. Eastland M.B.A.
E-voting on shares	Click here to vote

Key Management of Zentalis Pharmaceuticals Inc

Name	Title
Mr. Vincent A. Vultaggio	SVP of Finance & Principal Accounting Officer
Mr. Henry Gu	Senior VP & Head of Intellectual Property
Ms. Wendy Chang	Chief People Officer
Mr. Robert J. DiVasto P.E.	Senior Vice President of Technical Operations
Dr. Ingmar Bruns M.D., Ph.D.	Chief Medical Officer
Mr. Haibo Wang	Chief Business Officer
Mr. Rajesh Israni	Senior VP of Regulatory Affairs & Medical Writing
Ms. Julie M. Eastland M.B.A.	CEO, President & Director
Ms. Andrea Paul J.D.	Chief Legal Officer & Corporate Secretary

FAQs

What is Zentalis Pharmaceuticals Inc share price today?

Zentalis Pharmaceuticals Inc share price today is $1.5 as on September 13, 2025 at 1:29 am IST at the close of the market. Zentalis Pharmaceuticals Inc share today touched a day high of $1.55 and a low of $1.49.

What is the 52 week high and 52 week low for Zentalis Pharmaceuticals Inc share?

Zentalis Pharmaceuticals Inc share touched a 52 week high of $5.44 on September 16, 2024 and a 52 week low of $1.01 on April 9, 2025. Zentalis Pharmaceuticals Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $1.5,which is 72.43% down from its 52 week high and 48.51% up from its 52 week low.

What is Zentalis Pharmaceuticals Inc's market capitalisation today?

Zentalis Pharmaceuticals Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Zentalis Pharmaceuticals Inc Stock (ZNTL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Zentalis Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zentalis Pharmaceuticals Inc Shares that will get you 1.0000 shares as per Zentalis Pharmaceuticals Inc share price of $1.5 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Zentalis Pharmaceuticals Inc Stock (ZNTL) from India?

Indian investors can start investing in Zentalis Pharmaceuticals Inc (ZNTL) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 1:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Zentalis Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 1:37 pm IST). Based on Zentalis Pharmaceuticals Inc share’s latest price of $1.5 as on September 13, 2025 at 1:29 am IST, you will get 6.6667 shares of Zentalis Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Zentalis Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Zentalis Pharmaceuticals Inc stock has given -94.4% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?